C171H165ClF10N16O12S5 — CID 167577045
N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-[2-(difluoromethyl)phenyl]-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(2-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;bis(1-[6-fluoro-2-(3-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one);3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide (PubChem CID 167577045) has the molecular formula C171H165ClF10N16O12S5 and a molecular weight of 3022.07 g/mol. Its IUPAC name is N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-[2-(difluoromethyl)phenyl]-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(2-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;bis(1-[6-fluoro-2-(3-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one);3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide.
| Compound Name | N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-[2-(difluoromethyl)phenyl]-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(2-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;bis(1-[6-fluoro-2-(3-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one);3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide |
|---|---|
| PubChem CID | 167577045 |
| Molecular Formula | C171H165ClF10N16O12S5 |
| Molecular Weight | 3022.07 g/mol |
| Exact Mass | 3019.09 |
| IUPAC Name | N-(2-chlorophenyl)-3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]piperidine-1-carboxamide;1-[2-[2-(difluoromethyl)phenyl]-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;1-[6-fluoro-2-(2-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one;bis(1-[6-fluoro-2-(3-fluorophenyl)-1-[(1S,3R)-3-[2-(5-methylthiophen-2-yl)-2-oxoethyl]cyclohexyl]benzimidazol-5-yl]propan-1-one);3-[2-(3-fluorophenyl)-5-propanoylbenzimidazol-1-yl]-N-thiophen-2-ylpiperidine-1-carboxamide |
| SMILES | CCC(=O)c1cc2nc(-c3cccc(F)c3)n([C@H]3CCC[C@@H](CC(=O)c4ccc(C)s4)C3)c2cc1F.CCC(=O)c1cc2nc(-c3cccc(F)c3)n([C@H]3CCC[C@@H](CC(=O)c4ccc(C)s4)C3)c2cc1F.CCC(=O)c1cc2nc(-c3ccccc3F)n([C@H]3CCC[C@@H](CC(=O)c4ccc(C)s4)C3)c2cc1F.CCC(=O)c1ccc2c(c1)nc(-c1cccc(F)c1)n2C1CCCN(C(=O)Nc2ccccc2Cl)C1.CCC(=O)c1ccc2c(c1)nc(-c1cccc(F)c1)n2C1CCCN(C(=O)Nc2cccs2)C1.CCC(=O)c1ccc2c(c1)nc(-c1ccccc1C(F)F)n2[C@H]1CCC[C@@H](CC(=O)c2ccc(C)s2)C1 |
| InChI | InChI=1S/C30H30F2N2O2S.3C29H28F2N2O2S.C28H26ClFN4O2.C26H25FN4O2S/c1-3-26(35)20-12-13-25-24(17-20)33-30(23-10-5-4-9-22(23)29(31)32)34(25)21-8-6-7-19(15-21)16-27(36)28-14-11-18(2)37-28;2*1-3-26(34)22-15-24-25(16-23(22)31)33(29(32-24)19-7-5-8-20(30)14-19)21-9-4-6-18(12-21)13-27(35)28-11-10-17(2)36-28;1-3-26(34)21-15-24-25(16-23(21)31)33(29(32-24)20-9-4-5-10-22(20)30)19-8-6-7-18(13-19)14-27(35)28-12-11-17(2)36-28;1-2-26(35)18-12-13-25-24(16-18)31-27(19-7-5-8-20(30)15-19)34(25)21-9-6-14-33(17-21)28(36)32-23-11-4-3-10-22(23)29;1-2-23(32)17-10-11-22-21(15-17)28-25(18-6-3-7-19(27)14-18)31(22)20-8-4-12-30(16-20)26(33)29-24-9-5-13-34-24/h4-5,9-14,17,19,21,29H,3,6-8,15-16H2,1-2H3;2*5,7-8,10-11,14-16,18,21H,3-4,6,9,12-13H2,1-2H3;4-5,9-12,15-16,18-19H,3,6-8,13-14H2,1-2H3;3-5,7-8,10-13,15-16,21H,2,6,9,14,17H2,1H3,(H,32,36);3,5-7,9-11,13-15,20H,2,4,8,12,16H2,1H3,(H,29,33)/t19-,21+;2*18-,21+;18-,19+;;/m1111../s1 |
| InChIKey | GRICJXJQDMZHLF-GKKGWKAYSA-N |
| XLogP | 45.78 |
| TPSA | 342.30 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 39 |
| Heavy Atoms | 215 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3022.07 |
| LogP ≤ 5 | 45.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 29 |